This paper was originally published by Olivier J. Wouters and Panos G. Kanavos in BMC Health Services Research 2017 17:242 https://doi.org/10.1186/s12913-017-2184-5 © The Author(s). 2017 Abstract Background Policymakers and researchers frequently com…
The steep rise in pharmaceutical prices year over year is old news at this point. Even a number of generic drugs are going up in price, causing difficulties for insurers…
The post Rising Pharmaceutical Costs a Major Challenge for Managed Healthca…
Rising Pharmaceutical Costs a Major Challenge for Managed Healthcare Read Post »
Pharmaceutical competition incorporates different tactics in different markets because countries have divergent approaches to regulating healthcare costs. Both price and product have roles in defining the competitive landscape in pharmaceuticals,……
Should Price or Product Be the Determinant in Pharmaceutical Competition? Read Post »
We live in a digital world. The way we interact has undergone a tremendous change in the last decade and this change is gradually reshaping our society itself. It’s difficult…
The post How can pharmaceutical companies play a key role in the digit…
Blockchain based technologies will reach millions of lives Blockchain is making its entry into healthcare and medical fields, and is being prepared for the potential ways in which an ingenious…
The post Blockchain Applications in the Pharmaceutic…
Blockchain Applications in the Pharmaceutical Industry Read Post »
ALVESCO (ciclesonide) Astrazeneca pharmsPatent: 5,482,934Expiration: Oct 24, 2017 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit www.DrugP…
Drug Patent Expirations for the Week of October 22, 2017 Read Post »
This is part six of a six-part series on drug lifecycle management: Four Strategic ChoicesPrevention Innovation Extraction Adaptation Summary and Conclusion This article is adapted from Song CH, Han J-W. Patent cliff and strategic switch:…
The post Str…
Strategies for Branded Drug Lifecycle Management: Part 6 – Summary and Conclusion Read Post »
This is part five of a six-part series on drug lifecycle management: Four Strategic ChoicesPrevention Innovation Extraction Adaptation Summary and Conclusion This article is adapted from Song CH, Han J-W. Patent cliff and strategic switch:…
The post St…
Strategies for Branded Drug Lifecycle Management: Part 5 – Adaptation Read Post »
This is part four of a six-part series on drug lifecycle management: Four Strategic ChoicesPrevention Innovation Extraction Adaptation Summary and Conclusion This article is adapted from Song CH, Han J-W. Patent cliff and strategic switch:…
The post St…
Strategies for Branded Drug Lifecycle Management: Part 4 – Extraction Read Post »
This is part three of a six-part series on drug lifecycle management: Four Strategic ChoicesPrevention Innovation Extraction Adaptation Summary and Conclusion This article is adapted from Song CH, Han J-W. Patent cliff and strategic switch:…
The post S…
Strategies for Branded Drug Lifecycle Management: Part 3 – Innovation Read Post »